Meta-Analysis
Copyright ©The Author(s) 2018.
World J Hepatol. Nov 27, 2018; 10(11): 877-886
Published online Nov 27, 2018. doi: 10.4254/wjh.v10.i11.877
Table 1 Studies included in analysis - dobutamine stress echocardiography
Ref.TPFPFNTNTotal number of patients in the studyProportion of patients who underwent ICADefinition of patients includedCriteria for ICA indicationLesion for definition of positive ICAQUADAS-2 quality analysis criteria
Ibrahim et al[13]5852236610.9%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSENARB: P + I - R + F ? AC: P + I ? R +
Donovan et al[14]36181909.5%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 50%RB: P + I + R + F + AC: P + I + R +
Findlay et al[15]16001176%Cirrhotic patients in pre-LT evaluationTransplanted patients> 70%RB: P + I + R + F + AC: P – I + R +
Harinstein et al[16]27144110561%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 70%RB: P + I + R + F + AC: P + I + R +
Harinstein et al[16]45203510561%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 50%RB: P + I + R + F + AC: P + I + R +
Plotkin et al[17]200194052.5%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 70%RB: P + I + R + F + AC: P + I + R +
Ramrakhiani et al[18]410002017%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 70%RB: P + I – R – F ? AC: P + I – R –
Tsutsui et al[19]250102307.4%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 50%RB: P + I + R + F + AC: P + I + R +
Umphrey et al[20]00091575.7%Cirrhotic patients in pre-LT evaluationHigh risk patients> 70%RB: P + I + R + F + AC: P + I + R +
Snipelisky et al[21]1216201866100%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 50%RB: P + I + R + F + AC: P + I + R +
Patel et al[22]15105612442048.8%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive DSE> 70%RB: P + I + R + F + AC: P + I + R +
Table 2 Studies included for analysis - myocardial perfusion scintigraphy
Ref.TPFPFNTNTotal number of patients in the studyProportion of patients who underwent ICADefinition of patients includedCriteria for ICA indicationLesion for definition of positive ICAQUADAS-2 quality analysis criteria
Baker et al[23]840147435.1%Cirrhotic patients in pre-LT evaluation with cardiac risk factorsHigh risk patients/positive MPS> 70%RB: P – I + R + F + AC: P – I + R +
Kryzhanovski et al[24]0100631.6%Cirrhotic patients in pre-LT evaluation with cardiac risk factorsHigh risk patients/positive MPS> 70%RB: P – I + R + F + AC: P – I + R +
Senzolo et al[25]0200248.3%Cirrhotic patients in pre-LT evaluationPositive MPS> 70%RB: P – I + R + F + AC: P – I + R +
Kandiah et al[26]14059310.7%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive MPS> 70%RB: P – I + R + F + AC: P – I + R +
Oprea-Lager et al[27]11001561.2%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive MPS> 70%RB: P – I + R + F + AC: P – I + R +
Davidson et al[28]724124083100%Cirrhotic patients in pre-LT evaluation with cardiac risk factorsHigh risk patients/positive MPS> 70%RB: P + I + R + F + AC: P + I + R +
Aydinalp et al[29]63406438926.7%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive MPS> 50%RB: P + I + R + F + AC: P + I + R +
Zoghbi et al[30]2112128731%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive MPS> 70%RB: P – I + R + F + AC: P – I + R +
Bezinover et al[31]31391739.2%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive MPSNARB: P + I + R + F + AC: P + I + R +
Bhutani et al[32]20461221541470.7%Cirrhotic patients in pre-LT evaluationHigh risk patients/positive MPS> 70%RB: P + I + R + F + AC: P + I + R +